They also identified BCAR3 as a critical mediator of HEF1-induced migration, with amino acid mutations that disrupt the HEF1-BCAR3 interaction impairing cell migration, suggesting the potential of HEF1 as a biomarker for tumor progression. The gene discussed is BCAR3; the disease is neoplasm.